Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Operating expenses:
Research and development	$ 8,722,104	$ 16,825,198	$ 20,015,639	$ 20,182,960
General and administrative	1,888,376	1,876,230	5,882,346	5,430,518
Loss from operations	(10,610,480)	(18,701,428)	(25,897,985)	(25,613,478)
Interest income	833,772	1,243,687	2,696,061	2,236,188
Other income (expense)	83,471	(2,152)	103,916	(4,906)
Net loss	$ (9,693,237)	$ (17,459,893)	$ (23,098,008)	$ (23,382,196)
Net income (loss) per share - basic (in dollars per share)	$ (0.10)	$ (0.22)	$ (0.24)	$ (0.46)
Net income (loss) per share - diluted (in dollars per share)	$ (0.10)	$ (0.22)	$ (0.24)	$ (0.46)
Weighted average common shares outstanding - basic (in shares)	95,185,187	80,481,053	95,186,346	50,578,115
Weighted average common shares outstanding - diluted (in shares)	95,185,187	80,481,053	95,186,346	50,578,115